Table 4 Antibiotic and multidrug resistance of the UPEC’s isolates, n (%)
Antibiotics | Total isolates, n = 110 (%) | MDR, n = 70 (%) | Male, n = 24 (%) | Female, n = 86 (%) | *p | Hospital-acquired, n = 31 (%) | Community-acquired, n = 79 (%) | *p |
|---|---|---|---|---|---|---|---|---|
Amikacin | 11 (10.0) | 11 (15.9) | 4 (16.7) | 7 (8.1) | Â | 1 (3.2) | 10 (12.7) | Â |
Gentamicin | 31 (28.2) | 29 (41.4) | 11 (45.8) | 20 (23.3) | 0.0297 | 10 (32.3) | 21 (26.6) | Â |
Tobramycin | 21 (19.1) | 21 (30.0) | 10 (41.7) | 11 (12.8) | 0.0015 | 9 (29.0) | 12 (15.2) | Â |
Netilmicin | 6 (5.5) | 5 (7.1) | 2 (8.3) | 4 (4.7) | Â | 2 (6.5) | 4 (5.1) | Â |
Ampicillin | 78 (70.9) | 60 (85.7) | 20 (83.3) | 58 (67.4) | Â | 24 (77.4) | 54 (68.4) | Â |
Ampicillin–sulbactam | 61 (55.5) | 54 (77.1) | 15 (62.5) | 46 (53.5) |  | 18 (58.1) | 43 (54.4) |  |
Amoxicillin–clavulanic acid | 26 (23.6) | 23 (32.9) | 5 (20.8) | 21 (24.4) |  | 6 (19.4) | 20 (25.3) |  |
Piperacillin–tazobactam | 61 (55.5) | 54 (77.1) | 15 (62.5) | 46 (53.5) |  | 18 (58.1) | 43 (54.4) |  |
Cefazolin | 46 (41.8) | 45 (64.3) | 15 (62.5) | 31 (36.0) | 0.0202 | 16 (51.6) | 30 (38.0) | Â |
Cefotaxime | 20 (18.2) | 20 (28.6) | 5 (20.8) | 15 (17.4) | Â | 6 (19.4) | 14 (17.7) | Â |
Ceftazidime | 27 (24.5) | 27 (38.6) | 13 (54.2) | 14 (16.3) | 0.0001 | 12 (38.7) | 15 (19.0) | 0.0306 |
Ceftriaxone | 30 (27.3) | 30 (42.9) | 14 (58.3) | 16 (18.6) | 0.0001 | 13 (41.9) | 17 (21.5) | 0.0305 |
Cefepime | 29 (26.4) | 29 (41.4) | 14 (58.3) | 15 (17.4) | 0.0001 | 12 (38.7) | 17 (21.5) | Â |
Trimethoprim–sulfamethoxazole | 80 (72.7) | 59 (84.3) | 18 (75.0) | 62 (72.1) |  | 24 (77.4) | 56 (70.9) |  |
Ciprofloxacin | 52 (47.3) | 49 (70.0) | 17 (70.8) | 35 (40.7) | 0.0089 | 15 (48.4) | 37 (46.8) | Â |
Levofloxacin | 48 (43.6) | 45 (64.3) | 16 (66.7) | 32 (37.2) | 0.0314 | 13 (41.9) | 35 (44.3) | Â |
Norfloxacin | 18 (16.4) | 18 (25.7) | 3 (12.5) | 15 (17.4) | Â | 2 (6.5) | 16 (20.3) | Â |
Nitrofurantoin | 14 (12.7) | 12 (17.1) | 5 (20.8) | 9 (10.5) | Â | 4 (12.9) | 10 (12.7) | 0.0002 |
Ertapenem | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | Â | 0 (0.0) | 0 (0.0) | Â |
Imipenem | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | Â | 0 (0.0) | 0 (0.0) | Â |